Conversely, a decrease in acyl-ghrelin levels in RA patients under DMARDs and/or biologics was reported in comparison to controls (15, 22), whereas higher levels of total ghrelin were observed after treatment with a TNF-α blocker in comparison to controls (22, 40). This evidence concerns the gene TNF and rheumatoid arthritis.